SESSION 3 - METASTATIC DISEASE: SYSTEMIC THERAPY

mRCC: Anti-angiogenic Therapy

C. Porta

mRCC: Anti-angiogenic Therapy

C. Porta

Please set the zoomlevel of your browser to 100%.